15
NOV
2011

Northwest Bio To Present At Society Of Neuro-Oncology Annual Meeting

Posted By :
Comments : Off
Premier Gathering of Neuro-Oncology Specialists from Across the US and Abroad Multiple Company Initiatives During Four-Day Meeting BETHESDA, MD, November 15, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) (Northwest Bio) today announced that it will participate in the annual meeting of the Society of NeuroOncology (SNO) to be held at the Hyatt Regency, Orange County, California from November 17-20. SNO is the premier professional...
Read More
01
NOV
2011

Northwest Bio Announces Interview Of CEO Linda Powers In Today’s CEO/CFO Publication

Posted By :
Comments : Off
Describes DCVax® Science and Company’s Progress BETHESDA, MD, November 1, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) (Northwest Bio) today announced, as part of its program of public outreach and education, the availability online of an interview of Northwest Bio Chairman and CEO Linda Powers by CEO/CFO Publication. The interview describes in layman’s terms both the encouraging science behind DCVax® and the progress...
Read More
25
OCT
2011

Northwest Bio Announces Initiation Of S&P Coverage, With Publication Of First Company Stock Report

Posted By :
Comments : Off
To Be Made Available To 100,000 Participating Investment Advisors BETHESDA, MD, October 25, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) (NORTHWEST BIO) today announced initiation of Factual Stock Report coverage in conjunct- ion with Standard & Poor’s Market Access Program, an information distribution service that enables subscribing publicly traded companies to have corporate information disseminated to users of...
Read More
06
OCT
2011

Northwest Bio Announces Positive Third Quarter Progress

Posted By :
Comments : Off
Exceeds Projections, With 17 Active Clinical Trial Sites S&P To Initiate Coverage BETHESDA, MD, October 6, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) (NORTHWEST BIO) today announced that it has exceeded its Q3 projection of 15 clinical trial sites by the end of the quarter, with 17 sites at major medical institutions across the U.S. now open and active where patients can enroll in the Company’s ongoing clinical trial o...
Read More
04
OCT
2011

Northwest Bio Will Present At The Second Annual “Cancer Immunotherapy: A Long Awaited Reality Conference” At The New York Academy Of Medicine, October 6, 2011

Posted By :
Comments : Off
Timely Conference, Following Yesterday’s Announcement Of Nobel Prize Presentation Will Be Broadcast Live On the Web BETHESDA, MD, October 4, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) (NORTHWEST BIO) today announced that it will be presenting at the second annual Cancer Immunotherapy: A Long-Awaited Reality Conference on Thursday, October 6, at the New York Academy of Medicine in New York City. The single-day conference...
Read More